- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01721304
Decisionmaking for Abnormal Uterine Bleeding (AUB)
April 21, 2015 updated by: Lisa Hess, Indiana University
Decision Making Among Treatment Alternatives for Abnormal Uterine Bleeding (AUB)
The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making.
This study is a two-part study.
The first pilot tests the computerized tool to ensure it is understood by patients, then the second part is a randomized study (computerized tool versus usual care) to see if improvements are made in satisfaction and if there are reductions in decision regret.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making.
This study was designed to develop and test the use of ACA as part of routine clinical care for women diagnosed with AUB.
After pilot testing, the ACA survey is administered in this study where patients are assigned to receive the ACA or to usual care.
Study Type
Interventional
Enrollment (Actual)
380
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Indiana University
-
-
North Carolina
-
Southern Pines, North Carolina, United States, 28388
- Southern Pines Women's Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Have received a diagnosis of dysfunctional or abnormal uterine bleeding (AUB) that is recommended for treatment
- Have not yet selected or initiated treatment for current AUB diagnosis
- Be at least 18 years of age.
- Be possible candidates for either medical or surgical therapy
- Able to provide informed consent for treatment options for oneself
Exclusion Criteria:
- Are currently being treated for cancer
- Any cancer diagnosis within the past 2 years (other than non-melanoma skin cancer)
- AUB due to serious pelvic pathology, medications, pregnancy or systemic disease that limits their range of treatment options
- Are not recommended for surgical intervention
- Are not recommended for medical intervention
- Are under 18 years of age
- Have not received a diagnosis of AUB
- Are currently being treated for AUB
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Adaptive Conjoint Analysis
Computerized survey to elicit preferences
|
Computerized survey to elicit patient preferences
|
No Intervention: Usual care
Patients are counseled by their physician as usual
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Differences in patient-reported satisfaction between treatment groups
Time Frame: 6 weeks
|
Satisfaction with care as measured by the Functional Assessment of Chronic Illness Therapy-Treatment Satisfaction-Patient Scale (FACT-TS-PS)
|
6 weeks
|
Differences in decision regret between treatment groups
Time Frame: 6 weeks
|
Decision regret is measured by the Decision Regret Scale
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lisa M Hess, PhD, Indiana University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
October 25, 2012
First Submitted That Met QC Criteria
November 1, 2012
First Posted (Estimate)
November 4, 2012
Study Record Updates
Last Update Posted (Estimate)
April 22, 2015
Last Update Submitted That Met QC Criteria
April 21, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1009001853 (0904-66B)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abnormal Uterine Bleeding
-
Women and Infants Hospital of Rhode IslandActive, not recruitingAbnormal Uterine Bleeding | Abnormal Uterine Bleeding, Ovulatory Dysfunction | Abnormal Uterine Bleeding, Endometrial Hemostatic DysfunctionUnited States
-
University of California, DavisWashington University School of MedicineTerminatedUterine Bleeding Heavy | Abnormal Uterine Bleeding, UnspecifiedUnited States
-
Sisli Hamidiye Etfal Training and Research HospitalCompletedAbnormal Uterine Bleeding
-
Chulalongkorn UniversityUnknown
-
Mahidol UniversityCompletedAbnormal Uterine Bleeding | Endometrial BiopsyThailand
-
Ain Shams UniversityCompletedCesarean Section; Dehiscence | Abnormal Uterine Bleeding
-
Maxima Medical CenterUtrecht UniversityActive, not recruiting
-
The Cleveland ClinicCompletedAbnormal Uterine BleedingUnited States
-
Mahmoud Ramadan HafezRecruitingCesarean Section Niche and Abnormal Uterine BleedingEgypt
-
University of Texas Southwestern Medical CenterWithdrawnAdenomyosis | Abnormal Uterine Bleeding
Clinical Trials on Adaptive Conjoint Analysis
-
Baylor College of MedicineM.D. Anderson Cancer Center; Agency for Healthcare Research and Quality (AHRQ)Completed
-
University of Missouri-ColumbiaRecruitingShoulder Injuries | Patient Satisfaction | Internal Rotation Contracture-shoulderUnited States
-
University of Wisconsin, MadisonU.S. Department of EducationCompleted
-
Dr. Leslie MorlandSan Diego Veterans Healthcare System; Healing Breakthrough; Lykos TherapeuticsRecruitingPTSD | Relational ProblemsUnited States
-
American Institutes for ResearchWisconsin Center for Education Research; University of Nebraska College of...RecruitingEmotional DisturbancesUnited States
-
The University of Hong Kong-Shenzhen HospitalUnknownCervical Cancer | Artificial Intelligence | Radiotherapy Side Effect | BiomarkerChina
-
VA Office of Research and DevelopmentCompleted
-
University Hospital, EssenRecruitingCervical Carcinoma | Radiation | Adaptive Radiotherapy | Image Guided Radiotherapy | Gynecological Tumor | Optimization | Curative Treatment | Adaptive Radiation TherapyGermany
-
Universitaire Ziekenhuizen KU LeuvenVrije Universiteit Brussel; Fund for Scientific Research, Flanders, BelgiumRecruitingCerebral Visual ImpairmentBelgium
-
University of VermontCompleted